共 106 条
[1]
Sisson JC(2007)Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science? Eur J Nucl Med Mol Imaging 34 1129-1130
[2]
Avram AM(2007)Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray” Eur J Nucl Med Mol Imaging 34 772-786
[3]
Rubello D(2007)Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray” [letter to the editor] Eur J Nucl Med Mol Imaging 34 1699-1700
[4]
Gross MD(1993)Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years? J Nucl Med 34 1638-1641
[5]
Brans B(2009)Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis Eur J Endocrinol 161 771-777
[6]
Bodei L(2009)Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule Nucl Med Commun 30 169-175
[7]
Giammarile F(2009)Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models Eur J Clin Invest 39 51-57
[8]
Linden O(2009)Accuracy of two simple methods for estimation of thyroidal 131I kinetics for dosimetry-based treatment of Graves’ disease Med Phys 36 1212-1218
[9]
Luster M(2010)Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I? Nucl Med Commun 31 201-205
[10]
Oyen WJG(2009)Radioiodine therapy for thyroid volume reduction of large goitres Nucl Med Commun 30 466-471